Highlights
1 patent
About
Pharmaceutical-grade Cannabinoid Infusion Technology
Day Three Labs is a cannabinoid CPG ingredient manufacturer specializing in the development and commercialization of novel cannabis product solutions. The company is the developer of Unlokt, an ingestible cannabinoid remedy with a natural protein that shuttles the cannabis directly into circulation, protecting the delicate terpenes and cannabinoids while bypassing first-pass metabolization, thereby delivering the cannabis as intended.
Identity
| Name | Day Three Labs |
|---|---|
| Slug | day-three-labs |
| Type / kind | startup |
| Crunchbase ID | day-three-labs |
| Source _id | ThkXe3SVsZqK55E3rbrCzrqkpXeUss1mB1ZzplaCHqKA0YOZ7oOYUB |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Mar 2024 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ city | Jerusalem |
| HQ address | Jerusalem, Israel |
Web & social
| https://www.linkedin.com/company/80912216 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical Cannabis
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyHealthcarePatients
Business models
B2B2C
Tags
medical-cannabisdrug-developmentnovel-ingredientscannabispharmaceuticals
Funding
| Total raised | $6.1M |
|---|---|
| Current stage | Series A |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}